Exelixis Price to Sales Ratio 2006-2018 | EXEL

Historical PS ratio values for Exelixis (EXEL) over the last 10 years. The current P/S ratio for Exelixis as of April 25, 2019 is .
Exelixis P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-04-25 20.00 7.33
2018-12-31 19.67 $2.73 7.21
2018-09-30 17.72 $2.38 7.45
2018-06-30 21.52 $2.15 10.03
2018-03-31 22.15 $1.87 11.86
2017-12-31 30.40 $1.45 20.94
2017-09-30 24.23 $1.38 17.60
2017-06-30 24.63 $1.13 21.76
2017-03-31 21.67 $0.97 22.30
2016-12-31 14.91 $0.78 19.17
2016-09-30 12.79 $0.52 24.80
2016-06-30 7.81 $0.32 24.53
2016-03-31 4.00 $0.20 19.89
2015-12-31 5.64 $0.18 31.08
2015-09-30 5.61 $0.17 32.66
2015-06-30 3.76 $0.16 23.69
2015-03-31 2.57 $0.15 16.94
2014-12-31 1.44 $0.13 11.13
2014-09-30 1.53 $0.12 13.29
2014-06-30 3.39 $0.11 30.12
2014-03-31 3.54 $0.14 24.70
2013-12-31 6.13 $0.17 35.98
2013-09-30 5.82 $0.20 29.76
2013-06-30 4.54 $0.25 18.46
2013-03-31 4.62 $0.23 19.74
2012-12-31 4.57 $0.31 14.66
2012-09-30 4.83 $0.98 4.93
2012-06-30 5.53 $1.87 2.95
2012-03-31 5.18 $2.07 2.50
2011-12-31 4.74 $2.26 2.10
2011-09-30 5.46 $1.92 2.84
2011-06-30 8.96 $1.44 6.20
2011-03-31 11.33 $1.63 6.94
2010-12-31 8.21 $1.71 4.81
2010-09-30 3.92 $1.74 2.25
2010-06-30 3.47 $1.75 1.98
2010-03-31 6.07 $1.57 3.86
2009-12-31 7.37 $1.42 5.20
2009-09-30 6.38 $1.29 4.96
2009-06-30 4.87 $1.06 4.60
2009-03-31 4.60 $1.09 4.22
2008-12-31 5.02 $1.12 4.49
2008-09-30 6.08 $1.13 5.36
2008-06-30 5.00 $1.12 4.46
2008-03-31 6.95 $1.14 6.12
2007-12-31 8.63 $1.16 7.43
2007-09-30 10.59 $1.21 8.76
2007-06-30 12.10 $1.22 9.94
2007-03-31 9.94 $1.24 8.02
2006-12-31 9.00 $1.16 7.73
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.027B $0.854B
Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer. Exelixis is focusing its development and commercialization efforts primarily on COMETRIQ? (cabozantinib), its wholly-owned inhibitor of multiple receptor tyrosine kinases. Another Exelixis-discovered compound, cobimetinib, a selective inhibitor of MEK, is being evaluated by Roche and Genentech (a member of the Roche Group) in a broad development program under a collaboration with Exelixis.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $111.167B 12.52
Gilead Sciences (GILD) United States $81.772B 10.41
Celgene (CELG) United States $65.974B 11.22
Illumina (ILMN) United States $46.893B 54.38
Vertex Pharmaceuticals (VRTX) United States $44.640B 59.80
Biogen (BIIB) United States $44.574B 8.46
Regeneron Pharmaceuticals (REGN) United States $38.246B 17.77
Alexion Pharmaceuticals (ALXN) United States $30.320B 17.22
Incyte (INCY) United States $15.843B 147.88
BioMarin Pharmaceutical (BMRN) United States $15.217B 0.00
Exact Sciences (EXAS) United States $11.996B 0.00
Seattle Genetics (SGEN) United States $11.442B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.342B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
QIAGEN (QGEN) Netherlands $8.723B 28.87
Sarepta Therapeutics (SRPT) United States $8.571B 0.00
Moderna (MRNA) United States $8.468B 0.00
Bluebird Bio (BLUE) United States $7.656B 0.00
Bio-Techne Corp (TECH) United States $7.224B 48.67
BeiGene (BGNE) Cayman Islands $7.215B 0.00
Amarin (AMRN) Ireland $6.174B 0.00
Galapagos (GLPG) Belgium $5.782B 0.00
Guardant Health (GH) United States $5.618B 0.00
Array BioPharma (ARRY) United States $4.945B 0.00
Alkermes (ALKS) Ireland $4.755B 0.00
Ascendis Pharma (ASND) Denmark $4.695B 0.00
Horizon Pharma Public (HZNP) Ireland $4.666B 13.82
Spark Therapeutics (ONCE) United States $4.228B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.935B 0.00
China Biologic Products (CBPO) China $3.931B 24.36
ARGENX SE-ADR (ARGX) Netherlands $3.874B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.518B 0.00
Allogene Therapeutics (ALLO) United States $3.394B 0.00
Blueprint Medicines (BPMC) United States $3.391B 0.00
Global Blood Therapeutics (GBT) United States $3.181B 0.00
Immunomedics (IMMU) United States $3.173B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.060B 0.00
Amicus Therapeutics (FOLD) United States $3.056B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.850B 0.00
Emergent Biosolutions (EBS) United States $2.767B 23.02
Intercept Pharmaceuticals (ICPT) United States $2.640B 0.00
Repligen (RGEN) United States $2.523B 77.35
Genomic Health (GHDX) United States $2.453B 62.70
Akcea Therapeutics (AKCA) United States $2.449B 0.00
Ligand Pharmaceuticals (LGND) United States $2.444B 18.97
Halozyme Therapeutics (HALO) United States $2.355B 0.00
Insmed (INSM) United States $2.347B 0.00
Reata Pharmaceuticals (RETA) United States $2.334B 0.00
Denali Therapeutics (DNLI) United States $2.316B 0.00
Myriad Genetics (MYGN) United States $2.315B 23.58
Arena Pharmaceuticals (ARNA) United States $2.307B 0.00
Mirati Therapeutics (MRTX) United States $2.303B 0.00
MyoKardia (MYOK) United States $2.257B 0.00
Medicines (MDCO) United States $2.201B 0.00
Acceleron Pharma (XLRN) United States $2.168B 0.00
UniQure (QURE) Netherlands $2.124B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.068B 0.00
AnaptysBio (ANAB) United States $2.006B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.952B 0.00
REGENXBIO (RGNX) United States $1.931B 20.06
NeoGenomics (NEO) United States $1.931B 155.85
Audentes Therapeutics (BOLD) United States $1.718B 0.00
Allakos (ALLK) United States $1.674B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.651B 0.00
Atara Biotherapeutics (ATRA) United States $1.542B 0.00
Alector (ALEC) United States $1.479B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.454B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.435B 0.00
Innoviva (INVA) United States $1.374B 3.79
Cambrex (CBM) United States $1.368B 14.73
Rubius Therapeutics (RUBY) United States $1.364B 0.00
Lion Biotechnologies (IOVA) United States $1.361B 0.00
Editas Medicine (EDIT) United States $1.333B 0.00
Aimmune Therapeutics (AIMT) United States $1.318B 0.00
Puma Biotechnology (PBYI) United States $1.294B 0.00
InflaRx (IFRX) Germany $1.285B 0.00
Myovant Sciences (MYOV) United Kingdom $1.284B 0.00
Apellis Pharmaceuticals (APLS) United States $1.217B 0.00
Sangamo Therapeutics (SGMO) United States $1.212B 0.00
Epizyme (EPZM) United States $1.142B 0.00
Fate Therapeutics (FATE) United States $1.137B 0.00
Gossamer Bio (GOSS) United States $1.068B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.055B 0.00
Codexis (CDXS) United States $1.040B 0.00
Coherus BioSciences (CHRS) United States $1.037B 0.00
Clovis Oncology (CLVS) United States $1.012B 0.00
NGM BIOPHARMACT (NGM) United States $1.012B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.959B 0.00
RA PHARMCTL INC (RARX) United States $0.958B 0.00
WAVE Life Sciences (WVE) Singapore $0.948B 0.00
Genfit SA (GNFT) France $0.947B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.935B 0.00
Twist Bioscience (TWST) United States $0.927B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.926B 0.00
Eidos Therapeutics (EIDX) United States $0.925B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.917B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.877B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.875B 35.36
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.865B 0.00
ANI Pharmaceuticals (ANIP) United States $0.826B 15.11
Cellectis (CLLS) France $0.813B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.805B 0.00
Retrophin (RTRX) United States $0.803B 0.00
Vericel (VCEL) United States $0.771B 0.00
Cara Therapeutics (CARA) United States $0.771B 0.00
Intellia Therapeutics (NTLA) United States $0.764B 0.00
Intra-Cellular Therapies (ITCI) United States $0.742B 0.00
Arvinas (ARVN) United States $0.732B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.719B 0.00
Athenex (ATNX) United States $0.708B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.701B 0.00
G1 THERAPEUTICS (GTHX) United States $0.678B 0.00
Principia Biopharma (PRNB) United States $0.670B 0.00
Stemline Therapeutics (STML) United States $0.621B 0.00
Zealand Pharma (ZEAL) Denmark $0.619B 6.88
ObsEva SA (OBSV) Switzerland $0.614B 0.00
MeiraGTx Holdings (MGTX) United States $0.614B 0.00
Precision BioSciences (DTIL) United States $0.613B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.603B 0.00
Viking Therapeutics (VKTX) United States $0.601B 0.00
Heska (HSKA) United States $0.596B 53.49
Revance Therapeutics (RVNC) United States $0.589B 0.00
DBV Technologies (DBVT) France $0.568B 0.00
Kura Oncology (KURA) United States $0.561B 0.00
Axsome Therapeutics (AXSM) United States $0.556B 0.00
Magenta Therapeutics (MGTA) United States $0.545B 0.00
Zymeworks (ZYME) Canada $0.544B 0.00
Acorda Therapeutics (ACOR) United States $0.533B 6.90
Synthorx (THOR) United States $0.521B 0.00
Mesoblast (MESO) Australia $0.519B 0.00
Replimune (REPL) United States $0.517B 0.00
Cytokineticsorporated (CYTK) United States $0.512B 0.00
UROGEN PHARMA (URGN) United States $0.510B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.488B 0.00
Scholar Rock Holding (SRRK) United States $0.484B 0.00
AVROBIO (AVRO) United States $0.480B 0.00
Arcus Biosciences (RCUS) United States $0.476B 0.00
Krystal Biotech (KRYS) United States $0.474B 0.00
MediciNova (MNOV) United States $0.468B 0.00
Anika Therapeutics (ANIK) United States $0.464B 17.54
CytomX Therapeutics (CTMX) United States $0.446B 0.00
Sorrento Therapeutics (SRNE) United States $0.444B 0.00
KALEIDO BIOSCI (KLDO) $0.443B 0.00
Senesco Technologies (ELOX) United States $0.437B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.436B 0.00
PDL BioPharma (PDLI) United States $0.433B 9.66
Prothena (PRTA) Ireland $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.431B 0.00
Five Prime Therapeutics (FPRX) United States $0.431B 0.00
Dynavax Technologies (DVAX) United States $0.427B 0.00
CYCLERION THERA (CYCN) United States $0.423B 0.00
Adverum Biotechnologies (ADVM) United States $0.420B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.412B 0.00
STEALTH BIOTHER (MITO) United States $0.409B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.399B 0.00
Abeona Therapeutics (ABEO) United States $0.398B 0.00
Albireo Pharma (ALBO) United States $0.383B 0.00
Inovio Pharmaceuticals (INO) United States $0.375B 0.00
Kezar Life Sciences (KZR) United States $0.375B 0.00
Merus (MRUS) Netherlands $0.371B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Kindred Biosciences (KIN) United States $0.363B 0.00
Geron (GERN) United States $0.351B 0.00
Agenus (AGEN) United States $0.349B 0.00
BioDelivery Sciences (BDSI) United States $0.343B 0.00
XBiotech (XBIT) United States $0.342B 0.00
UNITY Biotechnology (UBX) $0.339B 0.00
PHASEBIO PHARMA (PHAS) United States $0.335B 0.00
Solid Biosciences (SLDB) United States $0.335B 0.00
AC Immune SA (ACIU) Switzerland $0.326B 0.00
BeyondSpring (BYSI) United States $0.319B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.313B 0.00
Constellation Pharmaceuticals (CNST) United States $0.312B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
MannKind (MNKD) United States $0.300B 0.00
LogicBio Therapeutics (LOGC) United States $0.300B 0.00
Kadmon Holdings (KDMN) United States $0.286B 0.00
Seres Therapeutics (MCRB) United States $0.284B 0.00
Aduro Biotech (ADRO) United States $0.283B 0.00
Kodiak Sciences (KOD) United States $0.271B 0.00
Evelo Biosciences (EVLO) United States $0.271B 0.00
ResTORbio (TORC) United States $0.266B 0.00
Strongbridge Biopharma (SBBP) United States $0.257B 0.00
Avid Bioservices (CDMO) United States $0.256B 0.00
Kala Pharmaceuticals (KALA) United States $0.255B 0.00
Enochian BioSciences (ENOB) United States $0.255B 0.00
Urovant Sciences (UROV) United States $0.253B 0.00
ChromaDex (CDXC) United States $0.253B 0.00
Arsanis (XFOR) United States $0.250B 0.00
Kamada (KMDA) Israel $0.247B 11.15
Xenon Pharmaceuticals (XENE) Canada $0.242B 0.00
Cerecor (CERC) United States $0.239B 0.00
Novavax (NVAX) United States $0.237B 0.00
Athersys (ATHX) United States $0.235B 0.00
Sutro Biopharma (STRO) United States $0.234B 0.00
Protagonist Therapeutics (PTGX) United States $0.233B 0.00
Cel-Sci (CVM) United States $0.230B 0.00
Palatin Technologies (PTN) United States $0.227B 112.00
Syros Pharmaceuticals (SYRS) United States $0.227B 0.00
OSMOTICA PHARM (OSMT) United States $0.221B 0.00
Celcuity (CELC) United States $0.220B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.217B 0.00
ADMA Biologics Inc (ADMA) United States $0.216B 0.00
OvaScience (MLND) United States $0.214B 0.00
TOCAGEN INC (TOCA) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.211B 0.00
Spero Therapeutics (SPRO) United States $0.210B 0.00
Gamida Cell (GMDA) Israel $0.205B 0.00
Intec Pharma (NTEC) Israel $0.200B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
Axovant Sciences (AXGT) United Kingdom $0.197B 0.00
CorMedix Inc (CRMD) United States $0.191B 0.00
VBI Vaccines (VBIV) United States $0.190B 0.00
Synlogic (SYBX) United States $0.189B 0.00
BioTime (BTX) United States $0.184B 0.00
Pfenex (PFNX) United States $0.184B 0.00
Compugen (CGEN) Israel $0.178B 0.00
Cue Biopharma (CUE) United States $0.175B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.175B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.171B 0.00
Menlo Therapeutics (MNLO) United States $0.168B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.167B 0.00
Enzo Biochem (ENZ) United States $0.165B 0.00
BioXcel Therapeutics (BTAI) United States $0.163B 0.00
Verastem (VSTM) United States $0.160B 0.00
Chiasma (CHMA) United States $0.149B 0.00
Mustang Bio (MBIO) United States $0.147B 0.00
Arbutus Biopharma (ABUS) Canada $0.147B 0.00
Liquidia Technologies (LQDA) United States $0.145B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.145B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.145B 0.00
Anavex Life Sciences (AVXL) United States $0.140B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.139B 0.00
Neothetics (EVFM) United States $0.138B 0.00
Trevena (TRVN) United States $0.136B 0.00
Allena Pharmaceuticals (ALNA) United States $0.134B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.129B 0.00
VolitionRX (VNRX) Singapore $0.129B 0.00
Provention Bio (PRVB) United States $0.128B 0.00
Checkpoint Therapeutics (CKPT) United States $0.127B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.127B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.122B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.119B 0.00
Organovo Holdings (ONVO) United States $0.118B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.108B 0.00
Unum Therapeutics (UMRX) United States $0.106B 0.00
XOMA (XOMA) United States $0.105B 0.00
INMUNE BIO INC (INMB) United States $0.103B 0.00
Cohbar (CWBR) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.098B 0.00
Fortress Biotech (FBIO) United States $0.098B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.095B 0.00
Selecta Biosciences (SELB) United States $0.094B 0.00
Equillium (EQ) United States $0.093B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.090B 0.00
NantKwest (NK) United States $0.089B 0.00
Signal Genetics (MGEN) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.084B 89.00
SESEN BIO, INC (SESN) United States $0.084B 0.00
Applied Genetic Technologies (AGTC) United States $0.084B 0.00
Alcobra (ARCT) United States $0.084B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.082B 0.00
Aptose Biosciences (APTO) Canada $0.081B 0.00
Eyenovia (EYEN) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.076B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
ScPharmaceuticals (SCPH) United States $0.067B 0.00
Zosano Pharma (ZSAN) United States $0.066B 0.00
AEterna Zentaris (AEZS) United States $0.064B 15.60
Cidara Therapeutics (CDTX) United States $0.064B 0.00
ARAVIVE, INC (ARAV) United States $0.064B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
Alimera Sciences (ALIM) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.062B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.061B 0.00
VTv Therapeutics (VTVT) United States $0.061B 0.00
Apricus Biosciences (SEEL) United States $0.061B 0.00
Curis (CRIS) United States $0.059B 0.00
Ophthotech (ISEE) United States $0.058B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.058B 0.00
Evogene (EVGN) Israel $0.057B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
Moleculin Biotech (MBRX) United States $0.050B 0.00
HOTH THERAPEUTC (HOTH) United States $0.050B 0.00
Entera Bio (ENTX) Israel $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
AZURRX BIOPHARM (AZRX) United States $0.046B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.046B 0.00
Celldex Therapeutics (CLDX) United States $0.046B 0.00
VistaGen Therapeutics (VTGN) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Celsion (CLSN) United States $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
ANCHIANO THERAP (ANCN) Israel $0.044B 0.00
Bellerophon Therapeutics (BLPH) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.042B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
VIVUS (VVUS) United States $0.039B 0.00
OncoSec Medical (ONCS) United States $0.037B 0.00
Leap Therapeutics (LPTX) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
Aptevo Therapeutics (APVO) United States $0.031B 0.00
Motif Bio Plc (MTFB) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Sophiris Bio (SPHS) United States $0.028B 0.00
GTx (GTXI) United States $0.027B 0.00
Vical (VICL) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.024B 0.00
Fibrocell Science Inc (FCSC) United States $0.024B 0.00
ATyr Pharma (LIFE) United States $0.023B 0.00
Oragenics (OGEN) United States $0.022B 0.00
Galena Biopharma (SLS) United States $0.021B 0.00
IMMURON LTD (IMRN) Australia $0.020B 0.00
TRACON Pharmaceuticals (TCON) United States $0.020B 0.00
Advaxis (ADXS) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
CytRx (CYTR) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Histogenics (HSGX) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Vital Therapies (IMUX) United States $0.016B 0.00
BioPharmX (BPMX) United States $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
Oncobiologics (OTLK) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Dare Bioscience (DARE) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.96
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
Edge Therapeutics (PDSB) United States $0.010B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Proteon Therapeutics (PRTO) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.002B 0.00